
LISCure Biosciences
Developer of bacteria-mediated immunotherapy designed to treat tumors as well as cancer. The company's immunotherapy is used by combining drugs, consisting of seven pipelines of medicine and two pipel...
Valuation
$0
Share Price
N/A
Total Raised
$47.5M
Last Round
N/A